These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8774498)

  • 1. Thrombosis in otherwise well children with the factor V Leiden mutation.
    Sifontes MT; Nuss R; Jacobson LJ; Griffin JH; Manco-Johnson MJ
    J Pediatr; 1996 Mar; 128(3):324-8. PubMed ID: 8774498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis.
    Sifontes MT; Nuss R; Hunger SP; Waters J; Jacobson LJ; Manco-Johnson M
    Am J Hematol; 1998 Jan; 57(1):29-32. PubMed ID: 9423813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.
    Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H
    Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
    Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U
    N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP; van Rumpt D; Hamulyák K; Reitsma PH; Bertina RM
    Thromb Haemost; 1995 Aug; 74(2):580-3. PubMed ID: 8584987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.
    Koeleman BP; Reitsma PH; Allaart CF; Bertina RM
    Blood; 1994 Aug; 84(4):1031-5. PubMed ID: 8049422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor V Leiden mutation in children with cancer and thrombosis.
    Sifontes MT; Nuss R; Hunger SP; Wilimas J; Jacobson LJ; Manco-Johnson MJ
    Br J Haematol; 1997 Mar; 96(3):484-9. PubMed ID: 9054652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden is not common in children with portal vein thrombosis.
    Seixas CA; Hessel G; Ribeiro CC; Arruda VR; Annichino-Bizzacchi JM
    Thromb Haemost; 1997 Feb; 77(2):258-61. PubMed ID: 9157577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family].
    Moia M; La Spina I; Padalino R; Carpenedo M
    Ann Ital Med Int; 1996; 11(1):17-9. PubMed ID: 8645525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation.
    McColl M; Tait RC; Walker ID; Perry DJ; McCall F; Conkie JA
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):689-94. PubMed ID: 8958391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
    Van Cott EM; Soderberg BL; Laposata M
    Arch Pathol Lab Med; 2002 May; 126(5):577-82. PubMed ID: 11958664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.